Quick answer
Chronic lung diseases such as emphysema and pulmonary fibrosis permanently damage alveoli and cut gas exchange. EHL Bio lists lung disease among conditions where stem cells hold potential, since MSCs are anti-inflammatory and anti-fibrotic. Human data, however, remain limited to small studies, so core treatment is still smoking cessation, inhaled bronchodilators, pulmonary rehabilitation and oxygen therapy where indicated.
